Trusted Resources: Education
Scientific literature and patient education texts
Early and Late Brain Resonance Findings of Two Siblings With Hunter Syndrome
source: Revista de Neurologia
year: 2021
authors: Silvestre-Avendaño JJ,Morales-Vásquez DE,Muñoz-Zuñiga JR
summary/abstract:Mucopolysaccharidosis type II (MPS II) is a lysosomal disease caused by deficiency of the enzyme iduronate-2-sulfatase (IDS), linked to the X chromosome, producing a wide spectrum of clinical manifestations.
organization: Universidad Nacional de Colombia, Bogotá DC, Colombia.DOI: 10.33588/rn.7301.2021203
read more
BookmarkRelated Content
-
Single Screening of Newborns for 8 Lysosomal Storage Diseases, Including MPS, PossibleResearchers have developed an efficient ...
-
Mount Sinai – Lysosomal Storage Disease ProgramThe Mount Sinai Hospital’s Lysosomal S...
-
What Is Mucopolysaccharidosishttps://www.onempsvoice.com/wp-content/u...
-
Establishing a Core Outcome set for Mucopolysaccharidoses (MPS) in Children: Study Protocol for a Rapid Literature R...Mucopolysaccharidoses (MPS) are a group ...
-
Sleep-Related Hypermotor Epilepsy in a Patient With Mucopolysaccharidosis Type IIIBoth non-epileptic sleep disturbances an...
-
Inhibition of Iduronic Acid Biosynthesis by Ebselen Reduces Glycosaminoglycan Accumulation in Mucopolysaccharidosis ...Mucopolysaccharidosis type I (MPS-I) is ...
-
Boston Children’s – Lysosomal Storage Disease Program (BoLD)The Boston Children's Lysosomal Storage ...
Powered by
